Nimenrix Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

After reconstitution, 1 dose (0.5 ml) contains: Neisseria meningitidis group A polysaccharide* 5 micrograms, Neisseria meningitidis group C polysaccharide* 5 micrograms, Neisseria meningitidis group W-135 polysaccharide* 5 micrograms, Neisseria meningitidis group Y polysaccharide* 5 micrograms.
*Conjugated to tetanus toxoid carrier protein 44 micrograms.
Excipients/Inactive Ingredients: Powder: Sucrose, Trometamol.
Solvent: Sodium chloride, Water for injections.

vaccine, meningococcal

Manufacturer:

Pfizer

Distributor:

Zuellig Pharma